Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease].

Vojnosanitetski pregled - 1 Jan 2007

Durić Gordana, Svetel Marina, Nikolaevic Sergej Illarioskin, Dragadević Natasa, Gavrilović Jelena, Kostić Vladimir S

Abstract excerpt

BACKGROUND/AIM: The presence of Parkinson's disease (PD) among the members of a family is a clear indication of the significance of genetics in its development. In spite of that, the majority of patients with PD shows a sporadic form of the disease induced as a result of interaction of both environmental and genetic factors. The aim of this study was to examine the effects of polymorphisms in the genes of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Aryldialkylphosphatase

Share to Cytochrome P-450 CYP2D6

Share to Genetic Predisposition to Disease

Share to Parkinson Disease

Share to Polymorphism, Genetic

Share to Risk Factors

Source

Identifiers

PMID: 17304721
DOI: 10.2298/vsp0701025d

Genes

PON1
APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease].PMID 17304721Read ↗

CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia.Semantic proximity Read ↗

Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.Semantic proximity Read ↗

Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism.Semantic proximity Read ↗

CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis.Semantic proximity Read ↗

CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key.Semantic proximity Read ↗

CYP2D6 phenotypes and Parkinson's disease risk: a meta-analysis.Semantic proximity Read ↗

[Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].Semantic proximity Read ↗

Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.Semantic proximity Read ↗

Parkinson's disease, CYP2D6 polymorphism, and age.Semantic proximity Read ↗

Roles of gender, age at onset and environmental risk in the frequency of CYP2D6-deficient alleles in patients with Parkinson's disease.Semantic proximity Read ↗

P450 enzymes and Parkinson's disease: the story so far.Semantic proximity Read ↗

Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.